MCAM and myeloid sarcoma: Blocking the entry of CD146+ T cells into the CNS is a potential MS therapeutic strategy.46,51 However, in the eCM model in our present study, deletion of CD146+ T cells did not show any beneficial effect on the prevention of eCM.